V Donnet

A Phase Ib, open-label, dose-finding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors

Jordi Rodón, Giuseppe Curigliano, Jean‐Pierre Delord et al. · Oncotarget · 2018 · 45 citations · Full text

Medicine, Oncology, Pharmacology +11

Phase I, open-label, multicentre study of buparlisib in combination with temozolomide or with concomitant radiation therapy and temozolomide in patients with newly diagnosed glioblastoma

Patrick Y. Wen, Jordi Rodón, Warren Mason et al. · ESMO Open · 2020 · 36 citations · Full text

Medicine, Oncology, Pharmacology +17

Buparlisib plus carboplatin or lomustine in patients with recurrent glioblastoma: a phase Ib/II, open-label, multicentre, randomised study

Mark Rosenthal, Paul M. Clément, Mario Campone et al. · ESMO Open · 2020 · 35 citations · Full text

Medicine, Oncology, Pharmacology +17

Alpelisib in combination with everolimus ± exemestane in solid tumours: Phase Ib randomised, open-label, multicentre study

Giuseppe Curigliano, Miguel Martín, Komal Jhaveri et al. · European Journal of Cancer · 2021 · 27 citations

Medicine, Oncology, Pharmacology +10